Laureate Education Updates IPO Filing
Laureate Education has amended its filing with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
All Work
Chris Lange
Why Lodging REITs Are Back in Style
Janney Capital believes these hotels are attractive in the later stages of the lodging cycle, given their high margins, consistent cash flows and potential for revenue per available room outperformance.
Deutsche Bank Settles With SEC Over Misleading Investors
The SEC has announced that Deutsche Bank agreed to settle charges in regards that it misled clients about the performance of a core feature of its automated order router that primarily sent client orders…
Jeld-Wen Closes in on IPO
Jeld-Wen Holding has again amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Why Key Analyst Sees More Challenges Ahead for Chipotle
One analyst took a somewhat negative perspective in its most recent call, which may explain why Chipotle may continue to be fundamentally overvalued.
Syndax Pharma Inks Key Agreement With National Cancer Institute
Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) is watching its shares make a handy gain on Wednesday after the firm reported a key agreement. Essentially, the company announced that it has entered into a Cooperative Research…
What to Look for in Adobe Earnings
Adobe Systems is set to release its fiscal fourth-quarter earnings report after the markets close on Thursday.
What to Expect From Oracle Earnings
Oracle is scheduled to report its fiscal second-quarter financial results after the markets close on Thursday.
TiGenix Updates IPO Terms
TiGenix intends to offer more than 2 million American depositary shares in its initial public offering and to list on the Nasdaq.
Neustar to Be Acquired by Golden Gate Capital
Shares of Neustar saw a solid gain on Wednesday after the company announced that it would be acquired by a private investment group led by Golden Gate Capital.
Renasant Closes in on Secondary Offering
Bank holding company Renasant will offer almost 2 million shares at $41.50 apiece in a secondary offering that is valued up to around $90 million.
Achaogen Prices Secondary Offering
Achaogen has priced its more than 6 million share offering at $13.50 per share in a secondary offering valued up to roughly $101 million.
Keane Group Files for IPO
Keane Group has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Vericel Wins on Key FDA Approval
Vericel shares jumped sharply early Wednesday after the company announced that the FDA has approved its treatment of symptomatic cartilage defects of the knee in adults.
Achaogen Gears Up for Secondary Offering
Achaogen, Inc. (NASDAQ: AKAO) saw its shares continue to rise late on Tuesday after the company reported that it would conduct a secondary offering. The company said that it would be offering up to…
SEC Charges Two Traders in $26 Million Stock Manipulation Scheme
The U. S. Securities and Exchange Commission (SEC) recently charged two New Jersey-based traders with manipulating more than 2,000 NYSE- and NASDAQ-traded stocks and making over $26 million in ill-gotten profits from their successful…
What to Expect From Pier 1 Earnings
Pier 1 Imports is scheduled to report its fiscal third-quarter financial results after the markets close on Wednesday.
Michaels Files for Secondary Offering
Shares of Michaels pulled back slightly after the company announced a secondary offering of up to 14 million shares.
Proteon Therapeutics Craters on Missed Late-Stage Results
Proteon Therapeutics saw its shares absolutely crater on Tuesday after the company reported top-line results from its late-stage chronic kidney disease trial.
aTyr Pharma Drops on Clinical Update
aTyr Pharma shares dropped early on Tuesday after the company announced clinical results from its exploratory trials assessing the safety and potential activity of Resolaris.